METASTATIC ESOPHAGEAL CARCINOMA
Clinical trials for METASTATIC ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cocktail targets tough stomach cancers
Disease control Recruiting nowThis study tests a mix of immune cells (agenT-797) and three immunotherapy drugs (botensilimab, balstilimab, ramucirumab) plus chemotherapy (paclitaxel) for people with advanced stomach, esophageal, or gastro-esophageal junction cancer that has worsened after one prior treatment.…
Matched conditions: METASTATIC ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Radiation boosts immune attack on stubborn GI cancers?
Disease control Recruiting nowThis study is for people with advanced gastrointestinal cancers that are spreading and no longer responding to immunotherapy. Researchers want to see if adding targeted radiation to one tumor can help the immune system fight cancer throughout the body. About 28 participants will …
Matched conditions: METASTATIC ESOPHAGEAL CARCINOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Could a common drug fight cancer wasting?
Symptom relief Recruiting nowThis study tests if olanzapine, a drug that affects brain chemicals, can help cancer patients who have lost their appetite and weight. The trial includes 66 adults with advanced lung, stomach, or colorectal cancers who are not being treated with a goal to cure. Participants will …
Matched conditions: METASTATIC ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Tumor tissue study aims to predict cancer treatment success
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a new diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 partici…
Matched conditions: METASTATIC ESOPHAGEAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC